|
2025
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
|
G/S
|
Pharmaceutical preparations and substances; sanitary preparations for medical purposes. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
G/S
|
Medical information services, namely, providing medical information on the topic of cancer; Onlin... |
|
|
G/S
|
Medical information services, namely, providing information related to vaccines for C Difficile i... |
|
|
G/S
|
Medical syringes; Medical apparatus, namely, infusion and injection devices for administering drugs |
|
|
G/S
|
Downloadable software in the nature of a mobile application for tracking injections for the treat... |
|
|
G/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
G/S
|
Medical apparatus, namely, infusion and injection devices for administering drugs; Medical syringes |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai... |
|
2024
|
Invention
|
Methods and vaccine compositions for lyme disease. Described are compositions and methods for pre... |
|
|
Invention
|
Solid forms of a gabaa receptor modulator and methods of its use. Solid crystalline forms of GABA... |
|
|
Invention
|
Inhibitors.
Described herein are novel compounds in an isolated or crystalline form, pharmaceuti... |
|
|
Invention
|
Nitrogen-containing heteroaryl compounds for the treatment of chronic diseases. The disclosure re... |
|
|
Invention
|
Improved methods for producing bacterial capsular saccharide glycoconjugates. The disclosure prov... |
|
|
Invention
|
Multiplexed biological assay device with electronic readout.
This invention relates generally to... |
|
|
Invention
|
Acetyl coa-carboxylase (acc) inhibitors. 12344 is H or OH; and, wherein the dashed line may be pr... |
|
|
Invention
|
Lipid compounds and uses thereof. Compounds are provided having the following structure: (I) or a... |
|
|
Invention
|
Lipid compounds and uses thereof. Compounds are provided having the following structure (I) or a ... |
|
|
Invention
|
Rna molecules. The present disclosure relates to RNA molecules encoding a respiratory syncytial v... |
|
|
Invention
|
Rna molecules. The present disclosure relates to RNA molecules encoding a Neisseria meningitidis ... |
|
|
Invention
|
Biphenyl and phenylpyridine compounds as inhibitors of kat2a and/or kat2b. The invention relates ... |
|
|
Invention
|
Biphenyl and phenylpyridine compounds.
The invention relates to compounds of Formula (1):
The ... |
|
|
Invention
|
Therapy for the treatment of multiple myeloma. Provided herein are methods of treating and/or man... |
|
|
Invention
|
Combination therapies for treatment of breast cancer. Provided are a combination therapy comprisi... |
|
|
Invention
|
Benzodiazepine compounds as n-protein inhibitors. The present disclosure relates to benzodiazepin... |
|
|
Invention
|
Combination therapies for treatment of breast cancer.
Provided are a combination therapy compris... |
|
|
Invention
|
Antibodies and antibody-drug conjugates specific for cd123 and uses thereof.
The present inventi... |
|
|
Invention
|
Novel antibodies and antibody conjugates for the treatment of metabolic disorders.
Disclosed her... |
|
|
Invention
|
Synthesis of 1,5-anhydro-3-({5-chloro-4-[4-fluoro-2-(2-hydroxypropan-2-yl)-1-(propan-2-yl)-1h-ben... |
|
|
Invention
|
Anti-gastric inhibitory polypeptide receptor (gipr) antibodies and antibody conjugates for the tr... |
|
|
Invention
|
Immunogenic compositions against influenza. The disclosure relates to compositions and methods fo... |
|
|
Invention
|
Anti-migis-alpha antibodies and methods of use thereof. Provided herein are antibodies (including... |
|
|
Invention
|
Anti-migis-alpha antibodies and methods of use thereof.
Provided herein are antibodies (includin... |
|
|
Invention
|
A crystalline form of 6-fluoro-3-(2,4,5-trifluoro-3-methoxyphenyl)-1-benzothiophene-2-carboxylic ... |
|
|
Invention
|
Tissue factor pathway inhibitor antibodies and uses thereof.
The invention relates to antibodies... |
|
|
Invention
|
Oral controlled-release matrix formulations of 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl... |
|
|
Invention
|
Toll-like receptor agonists and conjugates thereof. The invention relates to compounds and immuno... |
|
|
Invention
|
Method of forming multi-specific antibodies from homodimer antibodies and pharmaceutical product ... |
|
|
Invention
|
Chimeric antigen receptors targeting cd70.
The disclosure provides CARs (CARs) that specifically... |
|
|
Invention
|
Nitrile-containing antiviral compounds.
The invention relates to compounds of Formula I″
The i... |
|
|
Invention
|
Immunogenic compositions. The invention relates to lipid nanoparticles, immunogenic compositions ... |
|
|
Invention
|
Nitrogen-linked benzisoxazole sulfonamide derivatives.
The present invention relates to compound... |
|
|
Invention
|
Nitrogen-linked benzisoxazole sulfonamide derivatives for the treatment of cancer. The applicatio... |
|
|
Invention
|
Method for filling containers in sterile conditions with a pharmaceutical product and related fil... |
|
|
Invention
|
Methods for producing an adjuvant. This invention provides methods for producing homogeneous adju... |
|
|
Invention
|
Escherichia coli compositions and methods thereof.
In one aspect, the invention relates to an im... |
|
|
Invention
|
Escherichia coli compositions and methods thereof.
This invention relates to compositions that i... |
|
|
Invention
|
Lfa3 variants and compositions and uses thereof.
The invention provides LFA3 polypeptide molecul... |
|
|
Invention
|
Klf2 inducing deuterated compounds and uses thereof.
The present disclosure provides deuterated ... |
|
|
Invention
|
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acryla-mides.
The... |
|
|
Invention
|
Amphiphilic tlr7/8 adjuvants and uses thereof.
The invention relates to compounds of Formula (I)... |
|
2023
|
Invention
|
Methods for producing an adjuvant.
This invention provides methods for producing homogeneous and... |
|
|
Invention
|
Computerized decision support tool and medical device for respiratory condition monitoring and ca... |
|
|
Invention
|
Methods for incorporating azido groups in bacterial capsular polysaccharides.
The present invent... |
|
|
Invention
|
Coronavirus antigen variants.
The present disclosure provides isolated immunogenic polypeptides ... |
|
2022
|
Invention
|
Digital medicine companion for cdk inhibitor medications for cancer patients.
The present disclo... |
|
|
Invention
|
Melanocortin 4 receptor antagonists and uses thereof.
Described herein are compounds of Formula ... |
|
|
Invention
|
Methods and dosing regimens comprising a cdk2 inhibitor for the treatment of cancer.
The disclos... |
|
|
Invention
|
Solid forms of 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2s)-... |
